Literature DB >> 6378030

Treatment of gastroduodenal ulcers with carbonic anhydrase inhibitors.

I Puşcaş.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378030     DOI: 10.1111/j.1749-6632.1984.tb12392.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Identification of metal dithiocarbamates as a novel class of antileishmanial agents.

Authors:  Dhiman Sankar Pal; Dipon Kumar Mondal; Rupak Datta
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

Review 2.  Eradication of Helicobacter pylori Infection.

Authors:  Elizabeth A Marcus; George Sachs; David R Scott
Journal:  Curr Gastroenterol Rep       Date:  2016-07

3.  The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation.

Authors:  Elizabeth A Marcus; Amiel P Moshfegh; George Sachs; David R Scott
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

4.  Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?

Authors:  Claudiu T Supuran
Journal:  Front Pharmacol       Date:  2011-07-05       Impact factor: 5.810

Review 5.  Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets.

Authors:  Daniel P Flaherty; Mohamed N Seleem; Claudiu T Supuran
Journal:  Future Med Chem       Date:  2021-08-12       Impact factor: 4.767

6.  Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.

Authors:  Joyanta K Modak; Joyanta K Modakh; Yu C Liu; Mayra A Machuca; Claudiu T Supuran; Anna Roujeinikova
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Anti-Helicobacter pylori activity of ethoxzolamide.

Authors:  Joyanta K Modak; Alexandra Tikhomirova; Rebecca J Gorrell; Mohammad M Rahman; Despina Kotsanas; Tony M Korman; Jose Garcia-Bustos; Terry Kwok; Richard L Ferrero; Claudiu T Supuran; Anna Roujeinikova
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.